CoChat

Effects of a Synbiotic on Plasma Immune Activity Markers and Short-Chain Fatty Acids in Children and Adults with ADHD—A Randomized Controlled Trial

Open access

The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.

Abstract

Synbiotic 2000, a pre + probiotic, reduced comorbid autistic traits and emotion dysregulation in attention deficit hyperactivity disorder (ADHD) patients. Immune activity and bacteria-derived short-chain fatty acids (SCFAs) are microbiota–gut–brain axis mediators. The aim was to investigate Synbiotic 2000 effects on plasma levels of immune activity markers and SCFAs in children and adults with ADHD. ADHD patients (n = 182) completed the 9-week intervention with Synbiotic 2000 or placebo and 156 provided blood samples. Healthy adult controls (n = 57) provided baseline samples. At baseline, adults with ADHD had higher pro-inflammatory sICAM-1 and sVCAM-1 and lower SCFA levels than controls. Children with ADHD had higher baseline sICAM-1, sVCAM-1, IL-12/IL-23p40, IL-2Rα, and lower formic, acetic, and propionic acid levels than adults with ADHD. sICAM-1, sVCAM-1, and propionic acid levels were more abnormal in children on medication. Synbiotic 2000, compared to placebo, reduced IL-12/IL-23p40 and sICAM-1 and increased propionic acid levels in children on medication. SCFAs correlated negatively with sICAM-1 and sVCAM-1. Preliminary human aortic smooth-muscle-cell experiments indicated that SCFAs protected against IL-1β-induced ICAM-1 expression. These findings suggest that treatment with Synbiotic 2000 reduces IL12/IL-23p40 and sICAM-1 and increases propionic acid levels in children with ADHD. Propionic acid, together with formic and acetic acid, may contribute to the lowering of the higher-than-normal sICAM-1 levels.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu15051293

Cites

104 of 104 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Immune activity marker level comparisons between adult healthy controls and adult ADHD patients: Y-axes represent analyte levels. The differences between groups were analyzed using nonparametric Mann–Whitney U test, and FDR-adjusted p values are shown. Each dot represents a participant. Outliers (three for CRP and two for SAA) were excluded by the defined cutoff of more than 50* interquartile range (IQR) from the median.
Figure 1 Immune activity marker level comparisons between adult healthy controls and adult ADHD patients: Y-axes represent analyte levels. The differences between groups were analyzed using nonparametric Mann–Whitney U test, and FDR-adjusted p values are shown. Each dot represents a participant. Outliers (three for CRP and two for SAA) were excluded by the defined cutoff of more than 50* interquartile range (IQR) from the median.CC BY · PubMed Central
Figure 2 Differences in immune activity marker level between children and adults with ADHD at baseline. Y-axes represent analyte levels. The differences between groups were analyzed using nonparametric Mann–Whitney U test, and FDR-corrected p values are shown. Each dot represents a participant.
Figure 2 Differences in immune activity marker level between children and adults with ADHD at baseline. Y-axes represent analyte levels. The differences between groups were analyzed using nonparametric Mann–Whitney U test, and FDR-corrected p values are shown. Each dot represents a participant.CC BY · PubMed Central
Figure 3 Confidence intervals (CIs) for treatment effects of Synbiotic 2000, compared to placebo and adjusted by sex, on immune activity marker levels. CIs were from analysis of covariance models for (A) children; (B) adults; (C) children on ADHD medication during the last 3 months; (D) children not on ADHD medication during the last 3 months; (E) adults on ADHD medication during the last 3 months; (F) adults not on ADHD medication during the last 3 months. Dark colors indicate 95% CIs, and light colors indicate 99% CIs. ADHD medication includes methylphenidate, dexamphetamine, atomoxetine, and for adults also lisdexamphetamine. A CI below 0 means that Synbiotic 2000, compared to placebo, reduced the analyte levels. * Statistical significance (α = 0.01); # difference at α = 0.05; Outliers (three for CRP and two for SAA) were excluded by the defined cutoff of more than 50* interquartile range (IQR) from the median.
Figure 3 Confidence intervals (CIs) for treatment effects of Synbiotic 2000, compared to placebo and adjusted by sex, on immune activity marker levels. CIs were from analysis of covariance models for (A) children; (B) adults; (C) children on ADHD medication during the last 3 months; (D) children not on ADHD medication during the last 3 months; (E) adults on ADHD medication during the last 3 months; (F) adults not on ADHD medication during the last 3 months. Dark colors indicate 95% CIs, and light colors indicate 99% CIs. ADHD medication includes methylphenidate, dexamphetamine, atomoxetine, and for adults also lisdexamphetamine. A CI below 0 means that Synbiotic 2000, compared to placebo, reduced the analyte levels. * Statistical significance (α = 0.01); # difference at α = 0.05; Outliers (three for CRP and two for SAA) were excluded by the defined cutoff of more than 50* interquartile range (IQR) from the median.CC BY · PubMed Central
Figure 4 SCFA level comparisons at baseline (A) between healthy controls and ADHD patients for adults and (B) between children and adults with ADHD. Y-axes represent analyte levels. The differences between groups were analyzed using nonparametric Mann–Whitney U test and FDR-adjusted p values are shown. Each dot represents a participant.
Figure 4 SCFA level comparisons at baseline (A) between healthy controls and ADHD patients for adults and (B) between children and adults with ADHD. Y-axes represent analyte levels. The differences between groups were analyzed using nonparametric Mann–Whitney U test and FDR-adjusted p values are shown. Each dot represents a participant.CC BY · PubMed Central
Figure 5 Confidence intervals (CIs) for treatment effects of Synbiotic 2000, compared to placebo and adjusted by sex, on SCFAs. CIs were from analysis of covariance models among (A) children; (B) adults; (C) children on ADHD medication during the last 3 months; (D) children not on ADHD medication during the last 3 months; (E) adults on ADHD medication during the last 3 months; (F) adults not on ADHD medication during the last 3 months. Dark colors indicate 95% CIs, and light colors indicate 99% CIs. ADHD medication includes methylphenidate, dexamphetamine, atomoxetine, and for adults also lisdexamphetamine. A CI below 0 means that Synbiotic 2000, compared to placebo, reduced the analyte levels. * Statistical significance (α = 0.01); # difference at α = 0.05.
Figure 5 Confidence intervals (CIs) for treatment effects of Synbiotic 2000, compared to placebo and adjusted by sex, on SCFAs. CIs were from analysis of covariance models among (A) children; (B) adults; (C) children on ADHD medication during the last 3 months; (D) children not on ADHD medication during the last 3 months; (E) adults on ADHD medication during the last 3 months; (F) adults not on ADHD medication during the last 3 months. Dark colors indicate 95% CIs, and light colors indicate 99% CIs. ADHD medication includes methylphenidate, dexamphetamine, atomoxetine, and for adults also lisdexamphetamine. A CI below 0 means that Synbiotic 2000, compared to placebo, reduced the analyte levels. * Statistical significance (α = 0.01); # difference at α = 0.05.CC BY · PubMed Central
Figure 6 Correlation analysis between levels of immune activity markers and SCFAs in ADHD. Spearman’s rank correlation coefficients for (A) children before treatment; (B) children after treatment; (C) children for the change (follow up minus baseline) during the treatment; (D) adults before treatment; (E) adults after treatment; (F) adults for the change (follow up minus baseline) during the treatment. FDR-adjusted significant correlations (p < 0.050) are indicated in dark colors, and unadjusted correlations (p < 0.050) are indicated in light colors. Red indicates a positive correlation, and blue indicates negative correlation.
Figure 6 Correlation analysis between levels of immune activity markers and SCFAs in ADHD. Spearman’s rank correlation coefficients for (A) children before treatment; (B) children after treatment; (C) children for the change (follow up minus baseline) during the treatment; (D) adults before treatment; (E) adults after treatment; (F) adults for the change (follow up minus baseline) during the treatment. FDR-adjusted significant correlations (p < 0.050) are indicated in dark colors, and unadjusted correlations (p < 0.050) are indicated in light colors. Red indicates a positive correlation, and blue indicates negative correlation.CC BY · PubMed Central
Figure 7 Summary of the findings.
Figure 7 Summary of the findings.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 42

Metadata

Authors
Yang, L. L., Stiernborg, M., Skott, E., Xu, J., Wu, Y., Landberg, R., Arefin, S., Kublickiene, K., Millischer, V., Nilsson, I. A. K., Schalling, M., Giacobini, M., & Lavebratt, C.
Affiliations
  • Karolinska University Hospital (SE)
  • Karolinska Institutet (SE)
  • Chalmers University of Technology (SE)
Corresponding author
Lavebratt, Catharina
Venue
Nutrients
Publisher
MDPI AG
Published
2023-03-06
Volume
15
Issue
5
Pages
1293
ISSN
2072-6643 (ISSN-L)
OpenAlex
W4323313105
Cited by
42
References
104
Citations by year
2026: 14 · 2025: 11 · 2024: 14 · 2023: 3
FWCI
3.72
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Chalmers Research (Chalmers University of Technology) (submittedVersion)
Funders
  • Swedish Research Council (2014-10171, FO2020-0305, FO2021-0412, 2016-47, SLL20190589, LA2019-0013, LA2020-0006)
  • Swedish Brain Foundation (2014-10171, FO2020-0305, FO2021-0412, 2016-47, SLL20190589, LA2019-0013, LA2020-0006)
  • Ekhaga Foundation (2014-10171, FO2020-0305, FO2021-0412, 2016-47, SLL20190589, LA2019-0013, LA2020-0006)
  • the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet (2014-10171, FO2020-0305, FO2021-0412, 2016-47, SLL20190589, LA2019-0013, LA2020-0006)
  • Lindhés Advokatbyrå AB (2014-10171, FO2020-0305, FO2021-0412, 2016-47, SLL20190589, LA2019-0013, LA2020-0006)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
Keywords
synbiotics, attention deficit hyperactivity disorder, short-chain fatty acids, propionic acid, sICAM-1, sVCAM-1, IL-2 receptor alpha, microbiota-gut-brain axis, prebiotics, probiotics, children, adults, ADHD medication, ICAM-1 expression, autism spectrum disorder comorbidity, emotional dysregulation
MeSH terms
Adult, Attention Deficit Disorder with Hyperactivity, Child, Fatty Acids, Volatile, Humans, Propionates, Biomarkers, Interleukin-12, Synbiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.